CANC ETF holdings (NASDAQ) | MetaTrader

Abrir gráfico completo Full chart

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

RVMD Revolution Medicines Inc 10.06 M 98.58 K 6.29%

N

NVSEF Novartis AG 7.92 M 46.68 K 4.96%

BBIO Bridgebio Pharma Inc 7.60 M 114.32 K 4.75%

A

AZN AstraZeneca PLC 7.40 M 35.32 K 4.63%

LLY Eli Lilly & Co 6.91 M 6 565.00 4.32%

BMY Bristol-Myers Squibb Co 6.75 M 108.19 K 4.22%

Roche Holding AG 6.49 M 108.95 K 4.06%

MRK Merck & Co Inc 6.15 M 49.63 K 3.84%

A

ACLX Arcellx Inc 5.50 M 48.35 K 3.44%

COGT Cogent Biosciences Inc 5.26 M 135.36 K 3.29%

NUVL Nuvalent Inc 5.02 M 49.24 K 3.14%

GMAB Genmab A/S 5.00 M 169.72 K 3.13%

IMNM Immunome Inc 4.27 M 195.45 K 2.67%

JNJ Johnson & Johnson 4.04 M 16.26 K 2.53%

CELC Celcuity Inc 3.95 M 35.37 K 2.47%

AMGN Amgen Inc 3.93 M 10.12 K 2.46%

ABBV AbbVie Inc 3.88 M 16.71 K 2.43%

EXEL Exelixis Inc 3.51 M 79.64 K 2.19%

IDYA Ideaya Biosciences Inc 2.87 M 89.24 K 1.80%

ONC BeOne Medicines Ltd 2.84 M 8 960.00 1.78%

1
2
3

Notícias

GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks.com

Here's Why Biotech ETFs Are Rallying Hard

Be Thankful to These ETFs This Year

Inside the Recent Strength in Biotech ETFs

Biotech ETFs Bounce Back in 2025: Here's Why